| Antibiotic resistance in the food chain: a developing country-perspective LL Founou, RC Founou, SY Essack Frontiers in microbiology 7, 232834, 2016 | 692 | 2016 |
| Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis RC Founou, LL Founou, SY Essack PloS one 12 (12), e0189621, 2017 | 638 | 2017 |
| The development of β-lactam antibiotics in response to the evolution of β-lactamases SY Essack Pharmaceutical research 18, 1391-1399, 2001 | 229 | 2001 |
| Complexity and Diversity of Klebsiella pneumoniae Strains with Extended-Spectrum β-Lactamases Isolated in 1994 and 1996 at a Teaching Hospital in Durban … SY Essack, LMC Hall, DG Pillay, ML McFadyen, DM Livermore Antimicrobial agents and chemotherapy 45 (1), 88-95, 2001 | 229 | 2001 |
| Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres S Govender, V Pillay, DJ Chetty, SY Essack, CM Dangor, T Govender International journal of pharmaceutics 306 (1-2), 24-40, 2005 | 212 | 2005 |
| Colistin and tigecycline resistance in carbapenemase‐producing Gram‐negative bacteria: emerging resistance mechanisms and detection methods J Osei Sekyere, U Govinden, LA Bester, SY Essack Journal of applied microbiology 121 (3), 601-617, 2016 | 148 | 2016 |
| Antimicrobial resistance in the WHO African region: current status and roadmap for action SY Essack, AT Desta, RE Abotsi, EE Agoba Journal of public health 39 (1), 8-13, 2017 | 145 | 2017 |
| Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana N Agyepong, U Govinden, A Owusu-Ofori, SY Essack Antimicrobial Resistance & Infection Control 7, 1-8, 2018 | 143 | 2018 |
| Environment: the neglected component of the One Health triad SY Essack The Lancet Planetary Health 2 (6), e238-e239, 2018 | 130 | 2018 |
| Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance J Rodríguez-Baño, GM Rossolini, C Schultsz, E Tacconelli, S Murthy, ... Transactions of the royal society of tropical medicine and hygiene 115 (10 …, 2021 | 100 | 2021 |
| Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda CF Najjuka, DP Kateete, HM Kajumbula, ML Joloba, SY Essack BMC research notes 9, 1-14, 2016 | 94 | 2016 |
| Characterization of ESBLs in Salmonella spp. at a tertiary hospital in Durban South Africa SY 49. Govinden, U., Mocktar, C., Moodley, P., Sturm AW and Essack Diagnostic Microbiology and Infectious Disease 62, 86-91, 2008 | 89* | 2008 |
| Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper JY Maillard, SF Bloomfield, P Courvalin, SY Essack, S Gandra, CP Gerba, ... American journal of infection control 48 (9), 1090-1099, 2020 | 87 | 2020 |
| Review of established and innovative detection methods for carbapenemase‐producing Gram‐negative bacteria J Osei Sekyere, U Govinden, SY Essack Journal of applied microbiology 119 (5), 1219-1233, 2015 | 86 | 2015 |
| Diversity and proliferation of metallo-β-lactamases: a clarion call for clinically effective metallo-β-lactamase inhibitors AM Somboro, J Osei Sekyere, DG Amoako, SY Essack, LA Bester Applied and Environmental Microbiology 84 (18), e00698-18, 2018 | 81 | 2018 |
| NOTA: a potent metallo-β-lactamase inhibitor AM Somboro, D Tiwari, LA Bester, R Parboosing, L Chonco, HG Kruger, ... Journal of Antimicrobial Chemotherapy 70 (5), 1594-1596, 2015 | 77 | 2015 |
| Spread of plasmid-encoded NDM-1 and GES-5 carbapenemases among extensively drug-resistant and pandrug-resistant clinical Enterobacteriaceae in Durban, South Africa T Pedersen, JO Sekyere, U Govinden, K Moodley, A Sivertsen, ... Antimicrobial agents and chemotherapy 62 (5), 10.1128/aac. 02178-17, 2018 | 75 | 2018 |
| Prevalence of antibiotic resistance in Campylobacter isolates from commercial poultry suppliers in KwaZulu-Natal, South Africa LA Bester, SY Essack Journal of Antimicrobial Chemotherapy 62 (6), 1298-1300, 2008 | 75 | 2008 |
| A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa N Schellack, D Benjamin, A Brink, A Duse, K Faure, D Goff, M Mendelson, ... International journal of infectious diseases 64, 100-106, 2017 | 70 | 2017 |
| A Review of Moxifloxacin for the Treatment of Drug‐Susceptible Tuberculosis A Naidoo, K Naidoo, H McIlleron, S Essack, N Padayatchi The Journal of Clinical Pharmacology 57 (11), 1369-1386, 2017 | 68 | 2017 |
Dr. John Osei SekyereResearch Scientist, Department of Microbiology & Immunology, Indiana University School of MedicineVerified email at iu.edu
